Head-to-Head Comparison of Infliximab, Adalimumab in Crohn'sHead-to-Head Comparison of Infliximab, Adalimumab in Crohn's

In a rare comparison of infliximab and adalimumab in patients with Crohn's disease, long-term outcomes were assessed in a 'real-life situation.' Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news